1,744
Views
1
CrossRef citations to date
0
Altmetric
Cognition

Determining impairment in the Swedish, Polish and German ECAS: the importance of adjusting for age and education

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 475-484 | Received 23 Nov 2022, Accepted 13 Mar 2023, Published online: 30 Mar 2023

References

  • Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol. 2017;30:599–607.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
  • Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
  • Abrahams S, Newton JNE, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemp Degen. 2014;15:9–14.
  • ECAS International – ECAS [Internet]. Available at: https://ecas.psy.ed.ac.uk/ecas-international/. Accessed August 1, 2022.
  • Beswick E, Park E, Wong C, Mehta AR, Dakin R, Chandran S, et al. A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2021;268:4510–21.
  • Beswick E, Forbes D, Hassan Z, Wong C, Newton J, Carson A, et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2022;269:411–26.
  • Kourtesis P, Christidi F, Margioti E, Demenega C, Rentzos M, Evdokimidis I, et al. The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer’s disease in a Greek population. Amyotroph Lateral Scler Frontotemp Degen. 2020;21:78–85.
  • Taule T, Morland AS, Aßmus J, Tysnes OB, Rekand T. Translation, cultural adaptation, and validation of a screening test for cognitive and behavioural changes in amyotrophic lateral sclerosis. Disabil Rehab. 2021;0:1–9.
  • Mojtabavi H, Nafissi S, Mahmoodi-Bakhtiari B, Fathi D, Fatehi F. Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 2021;22:426–33.
  • Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:66–72.
  • Fazio R, Soósová N, Bak T, Růžička E, Bezdicek O. A normative study of the Czech Edinburgh Cognitive and Behavioural ALS Screen (ECAS): a brief report. Clin Neuropsychol. 2021;35:S65–S72.
  • Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese amyotrophic lateral sclerosis population. PLoS One. 2016;11:e0155496.
  • Mora JS, Salas T, Fernández MC, Rodríguez-Castillo V, Marín S, Chaverri D, et al. Spanish adaptation of the edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 2018;19:74–9.
  • Loose M, Burkhardt C, Aho-Özhan H, Keller J, Abdulla S, Böhm S, et al. Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener 2016;17:374–6.
  • Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 2016;17:489–98.
  • Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al. Derivation of norms for the Dutch version of the Edinburgh Cognitive and Behavioral ALS Screen. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:19–27.
  • De Icaza Valenzuela MM, Bak TH, Pal S, Abrahams S. The Edinburgh Cognitive and Behavioral ALS Screen: relationship to age, education, IQ and the Addenbrooke’s Cognitive Examination-III. Amyotroph Lateral Scler Frontotemp Degen. 2018;19:585–90.
  • Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:99–106.
  • Albertyn CH, Hardy A, Bakker LA, Hlangani M, Van Der Walt K, Zeilinga B, et al. Adaptation and norming of the Edinburgh Cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS) for three language groups in South Africa. Amyotroph Lateral Scler Frontotemp Degen. 2022;0:1–10.
  • Ye S, Rosenbohm A, Böhm S, Uttner I, Ji Y, Ludolph AC, et al. Cognitive and behavioral impairments in German and Chinese ALS populations – a post-hoc comparison of national study data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:28–36.
  • Doblhammer G, van den Berg GJ, Fritze T. Economic conditions at the time of birth and cognitive abilities late in life: evidence from ten European countries. PLoS One 2013;8:e74915.
  • Formanek T, Kagstrom A, Winkler P, Cermakova P. Differences in cognitive performance and cognitive decline across European regions: a population-based prospective cohort study. Eur Psychiatry. 2019;58:80–6.
  • Adam S, Bonsang E, Grotz C, Perelman S. Occupational activity and cognitive reserve: implications in terms of prevention of cognitive aging and Alzheimer’s disease. Clin Interv Aging. 2013;8:377–90.
  • Skirbekk V, Loichinger E, Weber D. Variation in cognitive functioning as a refined approach to comparing aging across countries. Proc Natl Acad Sci. 2012;109:770–4.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemp Degener. 2015;16:16–23.
  • Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17:268–74.
  • Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:649–54.
  • Andersen PM, Kuźma-Kozakiewicz M, Keller J, Maksymowicz-Śliwińska A, Barć K, Nieporęcki K, et al. Caregivers’ divergent perspectives on patients’ well-being and attitudes towards hastened death in Germany, Poland and Sweden. Amyotroph Lateral Scler Frontotemporal Degener 2022;23:252–62.
  • Finsel J, Uttner I, Medrano V, Ludolph CR, Lulé AC. D. Cognition in the course of ALS—a meta-analysis. Amyotroph Lateral Scler Frontotemp Degener. 2022;0:1–12.
  • Gosselt IK, Nijboer TCW, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:324–36.
  • Gutchess AH, Indeck A. Cultural influences on memory. In: Progress in brain research. Vol. 178. München: Elsevier; 2009:137–50.
  • Boduroglu A, Shah P, Nisbett RE. Cultural differences in allocation of attention in visual information processing. J Cross Cult Psychol. 2009;40:349–60.
  • SHARE-ERIC. The survey of health, ageing and retirement in Europe (SHARE): home [Internet]. 2022. Available at: http://www.share-project.org/home0.html. Accessed October 5, 2022.